Mast Therapeutics announced that positive interim data from its ongoing Phase 2a clinical trial of AIR001 (sodium nitrite, or…
Articles by Patrícia Silva, PhD
The Pulmonary Hypertension Association (PHA) has started a social media video campaign, A Heart Cures, asking people to make and…
Gilead Sciences reported that selonsertib (also known as GS-4997), an investigational treatment for pulmonary arterial hypertension (PAH), did not achieve…
The Pulmonary Hypertension Association (PHA) is planning a series of events for November, Pulmonary Hypertension Awareness Month, including a daylong focus on chronic…
Elsevier announced that it is expanding its work with the American College of Chest Physicians (CHEST) to provide CHEST members with…
The Pulmonary Hypertension Association (PHA) is organizing a series of events, called “PHA on the Road: PH Patients…
The Pulmonary Hypertension Association (PHA) is urging the U.S. Senate to support the Pulmonary Hypertension Research and Diagnosis Act…
The use of nitrite salts for the treatment of cardiovascular conditions, such as pulmonary hypertension, is now patented by the …
Rats with induced pulmonary hypertension (PH) and all its symptoms that were then treated with a modified strain of Lactobacillus,…
At the upcoming Evening of Hope Gala, the California chapter of the Pulmonary Hypertension Association (PHA) will recognize two pioneers…
Symple Surgical (SSI), a start-up medical device company, announced that it has entered into a development agreement with a confidential partner to advance…
Researchers identified two new drugs, both signaling inhibitors, that could aid in the treatment of pulmonary hypertension (PH) by altering vessel stiffness and…